rs587779778
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_000179.3(MSH6):c.1621A>C(p.Ser541Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,886 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S541G) has been classified as Likely benign.
Frequency
Consequence
NM_000179.3 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual developmental disorder with dysmorphic facies and behavioral abnormalitiesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251270 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461886Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Lynch syndrome 5 Pathogenic:1
- -
Inherited MMR deficiency (Lynch syndrome) Pathogenic:1
- -
Lynch syndrome Pathogenic:1
Multifactorial likelihood analysis posterior probability 0.95-0.99 -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.S541R variant (also known as c.1621A>C), located in coding exon 4 of the MSH6 gene, results from an A to C substitution at nucleotide position 1621. The serine at codon 541 is replaced by arginine, an amino acid with dissimilar properties. This alteration has been identified in several individuals who either met Amsterdam II criteria and/or had high microsatellite instability (MSI-H) in their tumor or had tumor results showing abnormal MSH6 staining on immunohistochemistry (Ambry internal data; Fokkema IF et al. Hum. Mutat., 2011 May;32:557-63; Raskin L et al. Oncotarget 2017 Nov;8(55):93450-93463). Based on internal structural analysis, p.S541R strongly perturbs the structure of the ATPase domain more than other known nearby likely pathogenic variants (Warren JJ et al. Mol. Cell, 2007 May;26:579-92). This alteration has been classified as likely pathogenic using the following lines of evidence: in silico prediction models, segregation with disease, clinical phenotype including tumor characteristics, mutation co-occurrence, and functional studies (Thompson BA et al. Hum. Mutat. 2013 Jan;34:200-9; Thompson BA et al. Nat. Genet. 2014 Feb;46:107-15; available at [www.insight-group.org/variants/classifications/]). This amino acid position is well conserved through mammals, but not in all available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. In addition, the CoDP in silico tool predicts this alteration to impair molecular function, with a score of 0.999 (Terui H et al. J. Biomed. Sci. 2013;20:25). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Mismatch repair cancer syndrome 3 Uncertain:1
- -
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 541 of the MSH6 protein (p.Ser541Arg). This variant is present in population databases (rs587779778, gnomAD 0.0009%). This missense change has been observed in individual(s) with colon cancer (PMID: 29212164, 31391288). ClinVar contains an entry for this variant (Variation ID: 126891). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MSH6 protein function with a negative predictive value of 95%. Experimental studies have shown that this missense change affects MSH6 function (PMID: 31965077). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at